prothrombin complex concentrate (beriplex pn) in severe bleeding experience in a large tertiary hospital凝血酶原复杂(beriplex pn)集中在严重出血的经验在一个大型三级医院.pdfVIP

下载本文档

2
0
约4.96万字
约 7页
2017-09-11 发布于上海
举报
版权申诉

prothrombin complex concentrate (beriplex pn) in severe bleeding experience in a large tertiary hospital凝血酶原复杂(beriplex pn)集中在严重出血的经验在一个大型三级医院.pdf

1、本文档共7页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

prothrombin complex concentrate (beriplex pn) in severe bleeding experience in a large tertiary hospital凝血酶原复杂(beriplex pn)集中在严重出血的经验在一个大型三级医院

Available online /content/12/4/R105 Vol 12 No 4 Open Access Research Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital David Bruce and Tim JC Nokes Department of Haematology, Derriford Hospital, Brest Road, Plymouth, Devon PL6 8DH, UK Corresponding author: Tim JC Nokes, tim.nokes@phnt.swest.nhs.uk Received: 7 Apr 2008 Revisions requested: 9 May 2008 Revisions received: 1 Jul 2008 Accepted: 15 Aug 2008 Published: 15 Aug 2008 Critical Care 2008, 12:R105 (doi:10.1186/cc6987) This article is online at: /content/12/4/R105 © 2008 Bruce and Nokes; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Introduction Major blood loss can often be life-threatening and 1). Therefore, 24 patients were included in the analysis: is most commonly encountered in the settings of surgery and coronary artery bypass graft (n = 5), mitral/aortic valve trauma. Patients receiving anticoagulant therapy are also at replacement (n = 2), other surgery (n = 9) and warfarin reversal increased risk of bleeding. We investigated the use of a (n = 8). Most patients (83.3%) received no more than 1500 IU prothrombin complex concentrate (PCC; Beriplex P/N, CSL of Beriplex P/N 500. Considerable reduction in administration of Behring, Marburg, Germany) to treat severe bleeding in a variety other blood products was seen